Importantly, the CD133+ cell population isolated from SCLCs was markedly more capable of initiating tumors in nude mice than the CD133low/- cell population: ASCL1 was shown to be critical for the tumor-initiating capacity of CD133+ SCLCs [205]. Here, PROM1 is linked to neoplasm.